How can synthetic biology obtain financing? These two companies have told us the answer!
Since 2025, the field of synthetic biology has experienced a wave of financing boom, with nearly a hundred domestic and foreign companies receiving capital favor.
Among them, Aijieboya, a leading enterprise in the domestic separation and purification field, announced on February 12th that it had completed a round of billion level financing, led by Huada Win Win Fund and Detong Capital, with continued follow-up investment from old shareholders and exclusive financial advisor from Life Capital.
This funding will help Aijieboya accelerate its layout in cutting-edge fields such as peptide drugs, nucleic acid drugs, ADC drugs, etc., and create a new generation of high-end technology equipment and solution platforms, providing more efficient technical support for downstream extraction, separation, and purification in biomanufacturing.
In the field of international synthetic biology, a biomaterial company called Modern Synthesis is also highly regarded.
The company was founded by a former Adidas designer and synthetic biologist, dedicated to transforming nanocellulose into new environmentally friendly textiles and coatings, providing sustainable and innovative solutions for the fashion industry.
Recently, Modern Synthesis announced the completion of a $5.5 million funding round led by Extantia Capital, with participation from Artesian and Collaborative Fund.
This funding will be used to expand its production capacity and collaborate with more fashion brands to promote the commercial application of environmentally friendly materials.
Nanocellulose is a natural polymer with a strength eight times that of steel at the nanofiber level, and is completely free of petroleum chemicals and toxic components.
Compared with traditional textiles, this new material has a smaller impact on the environment and can be regarded as a model of "green fashion". Modern Synthesis has partnered with Danish fashion brand GANNI to launch commercial products using their biomaterials.
Aijieboya provides efficient and precise separation and purification solutions for the biopharmaceutical industry through innovative separation of materials and precision fluid automation control, with chromatography technology as its core.
Modern Synthesis utilizes the high strength and versatility of nanocellulose to create eco-friendly textiles, injecting green concepts into the fashion industry.
From the United States, Europe to Asia, countries are increasing their investment in research and development of synthetic biology, promoting technological innovation and industrial applications.
The United States has always been at the forefront of basic research and technological innovation in synthetic biology, with numerous top research institutions and enterprises.
Europe has shown outstanding performance in the fields of biomaterials and sustainable development.
China has made rapid progress in the application research and industrialization of synthetic biology, especially in the fields of biopharmaceuticals, agriculture, and environmental protection.
In the future, from domestic high-end technology and equipment to international innovation in environmentally friendly materials, the Society of Synthetic Biology will gradually change our lives.
